J M Hoffman
Overview
Explore the profile of J M Hoffman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
3225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Austad S, Smith J, Hoffman J
Front Aging
. 2024 May;
5:1393216.
PMID: 38757144
Various so-called dietary restriction paradigms have shown promise for extending health and life. All such paradigms rely on (hereafter ) feeding, something virtually never employed in animals whose long-term health...
2.
Hammers D, Foster N, Hoffman J, Greene T, Duff K
J Prev Alzheimers Dis
. 2019 Nov;
6(4):242-247.
PMID: 31686096
Screen failure rates in Alzheimer's disease (AD) clinical trial research are unsustainable, with participant recruitment being a top barrier to AD research progress. The purpose of this project was to...
3.
Hoffman J, Lourenco B, Promislow D, Creevy K
J Small Anim Pract
. 2018 Jul;
59(11):681-690.
PMID: 30039567
Objective: To describe a large population of dogs with a diagnosis of hyperadrenocorticism at the time of death in North American veterinary teaching hospitals, and to identify comorbid conditions associated...
4.
Duff K, Hammers D, Dalley B, Suhrie K, Atkinson T, Rasmussen K, et al.
J Prev Alzheimers Dis
. 2017 Oct;
4(2):87-92.
PMID: 28966919
Background: Practice effects, which are improvements in cognitive test scores due to repeated exposure to testing materials, may provide information about Alzheimer's disease pathology, which could be useful for clinical...
5.
Freimuth R, Formea C, Hoffman J, Matey E, Peterson J, Boyce R
CPT Pharmacometrics Syst Pharmacol
. 2017 Jan;
6(3):153-155.
PMID: 28109071
The explosive growth of patient-specific genomic information relevant to drug therapy will continue to be a defining characteristic of biomedical research. To implement drug-based personalized medicine (PM) for patients, clinicians...
6.
Martin M, Hoffman J, Freimuth R, Klein T, Dong B, Pirmohamed M, et al.
Clin Pharmacol Ther
. 2014 Feb;
95(5):499-500.
PMID: 24561393
The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B Genotype and Abacavir Dosing were originally published in April 2012. We reviewed recent literature and concluded that none of the evidence...
7.
8.
Hicks J, Crews K, Hoffman J, Kornegay N, Wilkinson M, Lorier R, et al.
Clin Pharmacol Ther
. 2012 Sep;
92(5):563-6.
PMID: 22990750
No abstract available.
9.
Marcus R, Addison O, LaStayo P, Hungerford R, Wende A, Hoffman J, et al.
J Endocrinol Invest
. 2012 Apr;
36(2):111-7.
PMID: 22522495
Background: Aging is associated with a decline in skeletal muscle size.Muscle is critical both for mobility and glucose disposal. While resistance exercise (RE) increases muscle mass and function in the...
10.
Shenep L, Shenep M, Cheatham W, Hoffman J, Hale A, Williams B, et al.
J Hosp Infect
. 2011 Sep;
79(4):317-22.
PMID: 21945067
There is little published evidence regarding whether heparin lock solutions containing preservatives prevent catheter-related infections. However, adverse effects from preservative-containing flushes have been documented in neonates, leading many hospitals to...